ISSN: 1308-5727 | E-ISSN: 1308-5735
Volume : 7 Issue : 2 Year : 2024
Forms

Abstracting & Indexing
Turkish Society for Pediatric Endocrinology and Diabetes
Wolcott-Rallison Syndrome [J Clin Res Pediatr Endocrinol]
J Clin Res Pediatr Endocrinol. 2015; 7(2): 84-84

Wolcott-Rallison Syndrome

Fatih Gürbüz1, Bilgin Yüksel2, Ali Kemal Topaloğlu2
1Ankara Pediatric Hematology And Oncology Research And Training Hospital, Clinic Of Pediatric Endocrinology, Ankara, Turkey
2Çukurova University Faculty Of Medicine, Department Of Pediatric Endocrinology, Adana, Turkey

Wolcott-Rallison syndrome (WRS) is a rare autosomal recessive disorder characterized by early-infancy onset neonatal diabetes mellitus, epiphyseal dysplasia, and other multisystemic clinical manifestations. Mutations in the eukaryotic translation initiation factor 2? kinase (EIF2AK3) gene are responsible for this disorder. Here, we described a girl with neonatal diabetes diagnosed at 4 months of age, who developed severe growth retardation with epiphyseal dysplasia during the follow-up period. A clinical diagnosis of WRS was confirmed by the identification of a novel homozygous nonsense mutation (p.Q333*) in exon 5 of the EIF2AK3 gene in the consanguineous family. The clinical phenotype associated with the syndrome can be variable, but a combination of infancy-onset diabetes mellitus, multiple epiphyseal dysplasia, and hepatic and/or renal failure is the basis of diagnosis.

Keywords: Wolcott-Rallison syndrome, neonatal diabetes mellitus, epiphyseal dysplasia, EIF2AK3, mutation

Fatih Gürbüz, Bilgin Yüksel, Ali Kemal Topaloğlu. Wolcott-Rallison Syndrome. J Clin Res Pediatr Endocrinol. 2015; 7(2): 84-84
Manuscript Language: English
LookUs & Online Makale